Spyre Therapeutics CEO Cameron Turtle sells $1.38m in SYRE stock – FinSiddhi
Business News

Spyre Therapeutics CEO Cameron Turtle sells $1.38m in SYRE stock

FinSiddhi

Spyre Therapeutics CEO Cameron Turtle sells $1.38m in SYRE stock
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

Power Grid shares gain 1.5% after firm wins Rs 3,244 crore inter-state transmission system project. Should you buy?

Shares of Power Grid experienced an uptick after the company secured an important transmission project aimed at facilitating power evacuation from Rajasthan. This endeavor will incorporate the establishment of HVDC terminals and a long-distance transmission line. Power Grid’s successful bid for this vital project reflects its strategic growth, amidst varying stock performance observed in recent…

India’s Hockey teams set for Asian Games in white despite promise of blue jerseys

Hockey India president Dilip Tirkey had assured that India’s teams would wear blue at the Asian Games, but the first-choice kits reportedly feature predominantly white with light-blue accents. The discrepancy has revived the jersey debate that followed India’s switch to saffron ahead of the FIH World Cup. Efforts to arrange new kits have reportedly been…